⌘K

Home/Filings/4/0001304492-25-000012

4//SEC Filing

Ashe Gena L 4

Accession 0001304492-25-000012

CIK 0001304492other

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 5:27 PM ET

Size

5.8 KB

Accession

0001304492-25-000012

Insider Transaction Report

Form 4

Period: 2025-01-16

Anterix Inc.ATEX

Chief Legal Officer & Corp Sec

Transactions

Award
Stock Option (Right to Buy)
2025-01-16+37,275→ 37,275 total
Exercise: $27.83Exp: 2035-01-16→ Common Stock (37,275 underlying)

Footnotes (1)

[F1]The shares subject to this option shall vest and become exercisable in three equal annual installments with vesting commencing on January 16, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Documents

1 file

4
wk-form4_1737498468.xmlPrimary
FORM 4

Issuer

Anterix Inc.

CIK 0001304492

Entity typeother

Related Parties

1

filerCIK 0001669943

Filing Metadata

Form type: 4
Filed: Jan 20, 7:00 PM ET
Accepted: Jan 21, 5:27 PM ET
Size: 5.8 KB

View on SEC.gov